A
15.60
-0.71 (-4.32%)
| Penutupan Terdahulu | 16.31 |
| Buka | 16.18 |
| Jumlah Dagangan | 1,201,046 |
| Purata Dagangan (3B) | 1,033,304 |
| Modal Pasaran | 1,732,939,392 |
| Harga / Jualan (P/S) | 0.660 |
| Harga / Buku (P/B) | 6.30 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 7 May 2026 |
| Margin Operasi (TTM) | 16,317.06% |
| EPS Cair (TTM) | -3.10 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -99.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.69% |
| Nisbah Semasa (MRQ) | 12.05 |
| Aliran Tunai Operasi (OCF TTM) | -206.98 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -182.62 M |
| Pulangan Atas Aset (ROA TTM) | -40.72% |
| Pulangan Atas Ekuiti (ROE TTM) | -83.24% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Menaik | |
| Stok | Amylyx Pharmaceuticals, Inc. | Menaik | Menaik |
AISkor Stockmoo
-0.6
| Konsensus Penganalisis | 4.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -3.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -0.5 |
| Purata | -0.63 |
|
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 9.54% |
| % Dimiliki oleh Institusi | 85.89% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Commodore Capital Lp | 31 Dec 2025 | 5,650,000 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 34.00 (HC Wainwright & Co., 117.95%) | Beli |
| Median | 21.00 (34.62%) | |
| Rendah | 19.00 (B of A Securities, 21.80%) | Beli |
| Purata | 24.67 (58.14%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 14.39 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 04 Mar 2026 | 34.00 (117.95%) | Beli | 15.05 |
| 10 Feb 2026 | 28.00 (79.49%) | Beli | 14.89 | |
| Stifel | 03 Mar 2026 | 21.00 (34.62%) | Beli | 14.11 |
| B of A Securities | 20 Feb 2026 | 19.00 (21.79%) | Beli | 14.01 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |